Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

The benefits of blood pressure lowering treatment for prevention of cardiovascular disease are well established. However, the extent to which these effects differ by baseline blood pressure, presence of comorbidities, or drug class is less clear. We therefore performed a systematic review and meta-a...

Full description

Bibliographic Details
Main Authors:	Ettehad, D, Emdin, C, Kiran, A, Anderson, S, Callender, T, Emberson, J, Chalmers, J, Rodgers, A, Rahimi, K
Format:	Journal article
Language:	English
Published:	Elsevier 2015

Similar Items

Blood pressure lowering for cardiovascular disease - Authors' reply
by: Ettehad, D, et al.
Published: (2016)

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials
by: Salam, A, et al.
Published: (2018)

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
by: Rahimi, K, et al.
Published: (2021)

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data
by: Karmali, K, et al.
Published: (2018)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis
by: Lv, J, et al.
Published: (2012)

Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis
by: Pinho-Gomes, A-C, et al.
Published: (2021)

Cumulative in-trial and post-trial effects of blood pressure and lipid lowering: systematic review and meta-analysis.
by: Hirakawa, Y, et al.
Published: (2017)

Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data.
by: Sundström, J, et al.
Published: (2014)

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
by: Rahimi, K
Published: (2021)

Sex-specific effects of blood pressure lowering pharmacotherapy for the prevention of cardiovascular disease: an individual participant-level data meta-analysis
by: Bidel, Z, et al.
Published: (2023)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis.
by: Jicheng Lv, et al.
Published: (2012-01-01)

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials
by: Czernichow, S, et al.
Published: (2011)

Blood pressure lowering for cardiovascular disease
by: Collins, D, et al.
Published: (2016)

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
by: Nazarzadeh, M, et al.
Published: (2022)

How much lowering of blood pressure is required to prevent cardiovascular disease in patients with and without previous cardiovascular disease?
by: Canoy, D, et al.
Published: (2022)

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
by: Rahman, F, et al.
Published: (2019)

Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.
by: Ninomiya, T, et al.
Published: (2013)

Blood pressure and risk of vascular dementia: evidence from a primary care registry and a cohort study of transient ischemic attack and stroke
by: Emdin, C, et al.
Published: (2016)

Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial.
by: Arima, H, et al.
Published: (2012)

Blood pressure lowering and cardiovascular risk - Authors' reply.
by: Sundström, J, et al.
Published: (2014)

Blood pressure meta-analysis highlights an implementation gap - authors' reply
by: Rahimi, K, et al.
Published: (2022)

Atrial fibrillation and the risks of cardiovascular disease, renal disease and death: a meta-analysis
by: Odutayo, A, et al.
Published: (2016)

Cholesterol- and blood pressure-lowering drug use for secondary cardiovascular prevention in 2004 - 2013 Europe
by: Achelrod, D, et al.
Published: (2016)

Blood pressure-lowering treatment lowers mortality and cardiovascular disease risk, but whether effects differ at an arbitrary threshold of 140 mm Hg systolic blood pressure requires further research
by: Canoy, D, et al.
Published: (2018)

Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials
by: Pinho-Gomes, A, et al.
Published: (2019)

Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - authors' reply
by: Nazarzadeh, M, et al.
Published: (2022)

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial
by: Arima, H, et al.
Published: (2010)

Side-effects and tolerability of combination blood pressure lowering according to blood pressure levels – an analysis of the PROGRESS and ADVANCE trials
by: Atkins, A, et al.
Published: (2017)

Efficacy and safety of quarter dose blood pressure lowering agents: a systematic review and meta-analysis of randomised controlled trials
by: Bennett, A, et al.
Published: (2017)

Proportion and Characteristics of US Adults Who May Be Eligible From Additional Blood Pressure Lowering Based on Absolute Risk
by: Odutayo, A, et al.
Published: (2016)

The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports
by: Nazarzadeh, M, et al.
Published: (2022)

Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis
by: Odutayo, Ayodele, et al.
Published: (2017)

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.
by: Lewington, S, et al.
Published: (2007)

Blood pressure lowering-based prevention and the POWER trial
by: Vladimir Anatolyevich Parfenov, et al.
Published: (2013-03-01)

Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy
by: M Law, et al.
Published: (2003-11-01)

Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease
by: Chau Le Bao Ho, et al.
Published: (2022-10-01)

Time spent at blood pressure target and the risk of death and cardiovascular diseases.
by: Sheng-Chia Chung, et al.
Published: (2018-01-01)

Effect of statins on ventricular tachyarrhythmia, cardiac arrest, and sudden cardiac death: a meta-analysis of published and unpublished evidence from randomized trials.
by: Rahimi, K, et al.
Published: (2012)

Importance of mean blood pressure and blood pressure variability for the effect of valsartan versus amlodipine on cardiovascular events and death
by: Mehlum, MH, et al.
Published: (2018)

Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies.
by: Emdin, C, et al.
Published: (2016)